# Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine

> **NCT01311817** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** BMB72 (actA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein)

## Key facts

- **NCT ID:** NCT01311817
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311817, "Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01311817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*